136 related articles for article (PubMed ID: 8355916)
1. 99Tcm-MDP global skeletal uptake and markers of bone metabolism in patients with bone diseases.
Rubini G; Lauriero F; Rubini D; D'Addabbo A
Nucl Med Commun; 1993 Jul; 14(7):567-72. PubMed ID: 8355916
[TBL] [Abstract][Full Text] [Related]
2. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
3. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest.
D'Addabbo A; Rubini G; Mele M; Lauriero F
Nucl Med Commun; 1992 Jan; 13(1):55-60. PubMed ID: 1594171
[TBL] [Abstract][Full Text] [Related]
4. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
[TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
Pons F; Alvarez L; Peris P; Guañabens N; Vidal-Sicart S; Monegal A; Pavía J; Ballesta AM; Muños-Gómez J; Herranz R
Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
[TBL] [Abstract][Full Text] [Related]
6. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
Smith ML; Fogelman I; Ralston S; Boyce BF; Boyle IT
Metab Bone Dis Relat Res; 1984; 5(4):167-70. PubMed ID: 6429474
[TBL] [Abstract][Full Text] [Related]
7. Enhanced uptake of 99Tcm-MDP in skeletal metastases from prostate cancer following initiation of hormone treatment: potential for increasing delivery of therapeutic agents.
Bushnell DL; Madsen M; Kahn D; Nathan M; Williams RD
Nucl Med Commun; 1999 Oct; 20(10):875-81. PubMed ID: 10528290
[TBL] [Abstract][Full Text] [Related]
8. Atypical Paget's disease with quantitative assessment of tracer kinetics.
Gnanasegaran G; Moore AE; Blake GM; Vijayanathan S; Clarke SE; Fogelman I
Clin Nucl Med; 2007 Oct; 32(10):765-9. PubMed ID: 17885354
[TBL] [Abstract][Full Text] [Related]
9. The diphosphonate space: a useful quantitative index of disease activity in patients undergoing hydroxy methylene diphosphonate (HMDP) bone imaging for Paget's disease [corrected].
Evans A; Perkins A; Wastie M; Stone M; Hosking D
Eur J Nucl Med; 1991; 18(9):757-9. PubMed ID: 1809266
[TBL] [Abstract][Full Text] [Related]
10. Polyostotic Paget's disease.
Butt ST; Fatima S; Butt R; Nasir W; Jameel G; Irfan J
J Coll Physicians Surg Pak; 2012 Jul; 22(7):461-3. PubMed ID: 22747870
[TBL] [Abstract][Full Text] [Related]
11. Whole body retention of Tc-99m phosphate in Paget's disease of bone.
Hadjipavlou A; Lisbona R; Garbuz D; Abibtbol JJ
Clin Nucl Med; 1991 Jun; 16(6):435-8. PubMed ID: 1868658
[TBL] [Abstract][Full Text] [Related]
12. Bone alkaline phosphatase in Paget's disease.
Deftos LJ; Wolfert RL; Hill CS
Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
[TBL] [Abstract][Full Text] [Related]
13. Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.
Moore AE; Blake GM; Taylor KA; Rana AE; Wong M; Chen P; Fogelman I
J Bone Miner Res; 2010 May; 25(5):960-7. PubMed ID: 19929434
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with two simple methods of measurement of 99mTc-methylene diphosphonate body retention in bone disease.
Reschini E; Ulivieri FM; Ortolani S
J Nucl Biol Med (1991); 1991; 35(3):123-30. PubMed ID: 1816867
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic pulmonary osteoarthropathy in nasopharyngeal carcinoma: an early sign of pulmonary metastasis.
Liu RS; Chen YK; Yen SH; Chu YK; Chu LS; Chen KY; Yeh SH
Nucl Med Commun; 1995 Sep; 16(9):785-9. PubMed ID: 7478412
[TBL] [Abstract][Full Text] [Related]
16. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
[TBL] [Abstract][Full Text] [Related]
17. Increased accumulation of Tl-201 in monostotic Paget's disease of the patella: evaluation with quantitative analysis.
Abamor E; Kitapçi MT; Cila E; Gökçora N; Uluoğlu O
Clin Nucl Med; 2001 Jul; 26(7):615-8. PubMed ID: 11416743
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of circulating type I procollagen propeptides in patients with Paget's disease of bone.
Bonnin MR; Moragues C; Nolla JM; Lirón FJ; Roig-Escofet D; Navarro MA
Clin Chem Lab Med; 1998 Jan; 36(1):53-5. PubMed ID: 9594087
[TBL] [Abstract][Full Text] [Related]
19. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
[TBL] [Abstract][Full Text] [Related]
20. Evaluation by using radionuclide uptake of bone in Paget's disease of bone: special reference to treatment with calcitonin.
Dokoh S; Fukunaga M; Yamamoto I; Torizuka K; Morita R
Radioisotopes; 1988 Jun; 37(6):339-42. PubMed ID: 3212230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
